Volibris
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Volibris, covering 2026-04-22 to 2026-04-22. Get the full timeline:
Most recent: EMA Authorised: Volibris (ambrisentan) — GlaxoSmithKline Trading Services Limited